Abstract

Influenza viruses are a significant cause of respiratory infections, causing 3-5 million clinical infections and 250-500 thousand deaths per year. Infections caused by the influenza virus induce a host immune response at the non-specific and specific level (defined as natural and acquired), which leads to limitation of virus replication. Moreover the elements of immunological memory are induced so that they can protect against subsequent infection by the influenza virus. However, there is still no effective way for the total elimination of this virus, and the only effective method to combat this pathogen appears to be vaccination, which through immune system activation greatly limits its spread.The present paper presents the immune reaction at different levels in response to the influenza virus after entering the body and the mechanisms of the influenza virus for avoiding reactions of the immune system, which correspond to its high variability at the molecular level. Moreover, in this paper we describe various methods of stimulating the organism’s immune systems with different generations of vaccines and their effectiveness in the fight against this pathogen.

References

• 1. Aldridge J.R.Jr, Moseley C.E., Boltz D.A., Negovetich N.J., ReynoldsC., Franks J., Brown S.A., Doherty P.C., Webster R.G., ThomasP.G.: TNF/iNOS-producing dendritic cells are necessary evil of lethalinfluenza virus infection. Proc. Natl. Acad. Sci. USA, 2009; 106:5306-5311
  Google Scholar
• 2. Augustowicz E.: Wybrane elementy procesu wytwarzania szczepionekprzeciw grypie. Przegl. Epidemiol., 2010; 64: 373-380
  Google Scholar
• 3. Bielawska-Pohl A., Pajtasz-Piasecka E., Duś D.: Związki komórekNK z komórkami dendrytycznymi. Postępy Hig. Med. Dośw. 2013;67: 192-200
  Google Scholar
• 4. Brydak L.B.: Grypa. Pandemia grypy mit czy realne zagrożenie?Oficyna Wyd. Rytm, Warszawa 2008
  Google Scholar
• 5. Coleman J.R.: The PB1-F2 protein of influenza A virus: increasingpathogenicity by disrupting alveolar macrophages. Virol. J., 2007; 4: 9
  Google Scholar
• 6. Cox. M.M., Hashimoto Y.: A fast track influenza virus vaccineproduced in insect cells. J. Invertebr. Pathol., 2011; 107: S31-S41
  Google Scholar
• 7. Cox M.M., Hollister J.R.: FluBlok, a next generation influenzavaccine manufactured in insect cells. Biologicals, 2009; 37: 182-189
  Google Scholar
• 8. Cox R.J., Brokstad K.A., Ogra P.: Influenza virus: immunity andvaccination strategies. Comparision of the immune response to inactivatedand live, attenuated influenza vaccines. Scand. J. Immunol.,2004; 59: 1-15
  Google Scholar
• 9. Deptuła W., Tokarz-Deptuła B., Stosik M.: Immunologia dla biologów.Wyd. Uniwersytet Szczeciński, 2008
  Google Scholar
• 10. Dumit V.I., Dengjel J.: Autophagosomal protein dynamics andinfluenza virus infection. Front. Immunol., 2012; 3: 43
  Google Scholar
• 11. GeurtsvanKessel C.H., Lambrecht B.N.: Division of labor betweendendritic cells subsets of the lung. Mucosal Immunol., 2008; 1: 442-450
  Google Scholar
• 12. Hsu A.C., Parson K., Barr I., Lowther S., Middleton D., HansbroP.M., Wark P.A.: Critical role of constitutive type I interferon responsein bronchial epithelial cell to influenza infection. PLoS One,2012; 7: e32947
  Google Scholar
• 13. Hulo C., Castro E., Masson P., Bougueleret L., Bairoch A., XenariosI., Le Mercier P.: ViralZone: a knowledge resource to understandvirus diversity. Nucleic Acids Res., 2011; 39: D576-D582
  Google Scholar
• 14. Ichinohe T., Pang I.K., Kumamoto Y., Reaper D.R., Ho J.H., MurrayT.S., Iwasaki A.: Microbiota regulates immune defense againstrespiratory tract influenza A virus infection. Proc. Natl. Acad. Sci.USA, 2011; 108: 5354-5359
  Google Scholar
• 15. Jayasekera J.P., Vinuesa C.G., Karupiah G., King N.J.: Enhancedantiviral antibody secretion and attenuated immunopathology duringinfluenza virus infection in nitric oxide synthase-2-deficientmice. J. Gen. Virol., 2006; 87: 3361-3371
  Google Scholar
• 16. Kreijtz J.H., Fouchier R.A., Rimmelzwaan G.F.: Immune responsesto influenza virus infection. Virus Res., 2011; 162: 19-30
  Google Scholar
• 17. La Gruta N.L., Turner J.: T cell mediated immunity to influenza:mechanisms of viral control. Trends Immunol., 2014; 35: 396-402
  Google Scholar
• 18. McGill J., Heusel J.W., Legge K.L.: Innate immune control and regulationof influenza virus infections. J. Leuk. Biol., 2009; 86: 803-812
  Google Scholar
• 19. Mishra N.: Emerging influenza A/H1N1: challenges and development.The Health, 2011; 1: 16- 22
  Google Scholar
• 20. Mrukowicz J., Gładysz A., Sawiec P.: Wybrane choroby wirusowe.Grypa. W: Choroby wewnętrzne, red. A. Szczeklik, 2011
  Google Scholar
• 21. Narasaraju T., Yang E.I., Samy R.P., Ng H.H., Poh W.P., Liew A.A.,Phoon M.C., von Rooijen N., Chow V.T.: Excessive neutrophils andneutrophil extracellular traps contribute to acute lung injury of influenzapneumonitis. Am. J. Pathol., 2011; 179: 199-210
  Google Scholar
• 22. Niedźwiedzka-Rystwej P., Deptuła W.: Pryszczyca i ptasia grypa– groźne zoonozy. Laboratorium, 2009; 3: 50-53
  Google Scholar
• 23. Paget C., Ivanov S., Fontaine J., Blanc F., Pichavant M., RennesonJ., Bialecki E., Pothlichet J., Vendeville C., Barba-Spaeth G., HuerreM.R., Faveeuw C., Si-Tahar M., Trottein F.: Potential role of invariantNKT cells in the control of pulmonary inflammation and CD8+ T cellresponse during acute influenza A virus H3N2 pneumonia. J. Immunol.,2011; 186: 5590- 5602
  Google Scholar
• 24. Pang I.K., Iwasaki A.: Inflammasomes as mediators of immunityagainst influenza virus. Trends Immunol., 2011; 32: 34-41
  Google Scholar
• 25. Pulendran B., Ahmed R.: Immunological mechanisms of vaccination.Nature Immunol., 2011; 12: 509-517
  Google Scholar
• 26. Thompson C.M., Petiot E., Lennaertz A., Henry O., Kamen A.A.:Analytical technologies for influenza virus-like particle candidatevaccines: challenges and emerging approaches. Virol. J., 2013; 10: 141
  Google Scholar
• 27. Tong S., Zhu X., Li Y., Shi M., Zhang J., Bourgeois M., Yang H.,Chen X., Recuenco S., Gomez J., Chen L.M., Johnson A., Tao Y., DreyfusC., Yu W. i wsp.: New world bats harbor diverse influenza A viruses.PLoS Pathog., 2013; 9: e1003657
  Google Scholar
• 28. Treanor J.J., El Sahly H., King J., Graham I., Izikson R., KohbergerR., Patriarca P., Cox M.: Protective efficacy of a trivalent recombinanthemagglutinin protein vaccine (FluBlok) against influenzain healthy adults: A randomized, placebo-controlled trail. Vaccine,2011; 29: 7733-7739
  Google Scholar
• 29. WHO: Influenza fact sheet no. 211. http://www.who.int/mediacentre/factsheets/2003/fs211/en/(12.12.2014)
  Google Scholar
• 30. Zammit D.J., Turner D.L., Klonowski K.D., Lefrançois L., CauleyL.S.: Residual antigen presentation after influenza virus infectionaffects CD8 T cell activation and migration. Immunity, 2006;24: 439-449
  Google Scholar

Full text